Abstract:It is now increasingly appreciated that inflammation is not limited to the control of pathogens by the host, but rather that sterile inflammation which occurs in the absence of viral or bacterial pathogens, accompanies numerous disease states, none more so than the complications that arise as a result of hyperglycaemia. Individuals with type 1 or type 2 diabetes mellitus (T1D, T2D) are at increased risk of developing cardiac and vascular complications. Glucose and blood pressure lowering therapies have not stopped the advance of these morbidities that often lead to fatal heart attacks and/or stroke. A unifying mechanism of hyperglycemia-induced cellular damage was initially proposed to link elevated blood glucose levels with oxidative stress and the dysregulation of metabolic pathways. Pre-clinical evidence has, in most cases, supported this notion. However, therapeutic strategies to lessen oxidative stress in clinical trials has not proved efficacious, most likely due to indiscriminate targeting by antioxidants such as vitamins. Recent evidence now suggests that oxidative stress is a major driver of inflammation and vice versa, with the latest findings suggesting not only a key role for inflammatory pathways underpinning metabolic and haemodynamic dysfunction in diabetes, but furthermore that these perturbations are driven by activation of the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome. This review will address these latest findings with an aim of highlighting the interconnectivity between oxidative stress, NLRP3 activation and inflammation as it pertains to cardiac and vascular injury sustained by diabetes. Current therapeutic strategies to lessen both oxidative stress and inflammation will be emphasized. This will be placed in the context of improving the burden of these diabetic complications.

Mitochondria and T2D: Role of Autophagy, ER Stress, and Inflammasome

Relationship Between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues

Mitochondrial dysfunction and mitophagy in type 2 diabetes: pathophysiology and therapeutic targets

Mitochondrial Dysfunction, Oxidative Stress, and Inter-Organ Miscommunications in T2D Progression

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

Mitophagy and mitochondrial dynamics in type 2 diabetes mellitus treatment

Β-Cell Dynamics in Type 2 Diabetes and in Dietary and Exercise Interventions

Autophagy and Mitochondria in Obesity and Type 2 Diabetes

The Complex Interplay between Imbalanced Mitochondrial Dynamics and Metabolic Disorders in Type 2 Diabetes

Type 2 diabetes mellitus and neurodegenerative disorders: The mitochondrial connection

Mitochondrial Dysfunction, Oxidative Stress, and Therapeutic Strategies in Diabetes, Obesity, and Cardiovascular Disease

New therapeutic directions in type II diabetes and its complications: mitochondrial dynamics

Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications

Integrative Analyses of Mitophagy-Related Genes and Mechanisms Associated with Type 2 Diabetes in Muscle Tissue

Mitochondrial bioenergetics, metabolism, and beyond in pancreatic β-cells and diabetes

Inter-organ crosstalk during development and progression of type 2 diabetes mellitus

Dysregulated autophagy: A key player in the pathophysiology of type 2 diabetes and its complications

Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition

Metabolic reprogramming of macrophages in the context of type 2 diabetes